This week, Beyond Biotech concluded its three-part series on Genprex's approach to diabetes treatment through one-time gene therapy, exploring the company's bet on a fundamentally different model for managing a disease typically controlled through ongoing medication. The episode highlighted the clinical and commercial tensions inherent in developing curative therapies for chronic conditions, where the promise of a single treatment must overcome both regulatory hurdles and the established economics of disease management.
Episodes This Week
Get a free sample digest — no signup needed
Real AI summaries from top beyond biotech podcasts, straight to your inbox.
or
No spam, unsubscribe anytime. We'll send one sample digest, then you decide.
Other Weeks
This Week in Beyond Biotech (Oct 19 - Oct 25, 2026)
1 episode · Oct 19 – Oct 25
This Week in Beyond Biotech (Oct 12 - Oct 18, 2026)
1 episode · Oct 12 – Oct 18
This Week in Beyond Biotech (Oct 5 - Oct 11, 2026)
1 episode · Oct 5 – Oct 11
This Week in Beyond Biotech (Sep 28 - Oct 4, 2026)
1 episode · Sep 28 – Oct 4
This Week in Beyond Biotech (Sep 21 - Sep 27, 2026)
1 episode · Sep 21 – Sep 27
This Week in Beyond Biotech (Sep 14 - Sep 20, 2026)
1 episode · Sep 14 – Sep 20
This Week in Beyond Biotech (Sep 7 - Sep 13, 2026)
1 episode · Sep 7 – Sep 13
This Week in Beyond Biotech (Aug 31 - Sep 6, 2026)
1 episode · Aug 31 – Sep 6
This Week in Beyond Biotech (Aug 24 - Aug 30, 2026)
1 episode · Aug 24 – Aug 30
This Week in Beyond Biotech (Aug 17 - Aug 23, 2026)
1 episode · Aug 17 – Aug 23
This Week in Beyond Biotech (Aug 10 - Aug 16, 2026)
1 episode · Aug 10 – Aug 16